Interventional psychopharmacology

I combine clinical experience in intravenous ketamine with research on rapid-acting and emerging psychiatric treatments. My work also examines psychedelics, oxytocin, and novel medications through clinical research and evidence synthesis. I am interested in understanding who benefits, how long improvements last, and how these treatments can be integrated responsibly into care.